IP Library Granted Patent US 10,064,977
Granted Patent B2
US 10,064,977 · App. 15/006,287 · Granted Sep 4, 2018

Wet-pack intraocular lens materials with high refractive index

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,064,977
App. No.
15/006,287
Granted
Sep 4, 2018
Kind
B2
Abstract

Intraocular lens materials are disclosed. They are soft and very deformable and have a high refractive index, and a high glistening resistance in fully hydrated state. They are particularly suitable for making wet-packed intraocular lenses (IOLs) which can be delivered through sub 2.0 mm incisions.

Claims (35)

1. A polymeric intraocular lens material, which is polymerization product of a polymerizable composition comprising

(a) from about 10% to about 30% by weight of a hydrophilic monomer relative to the total amount of all polymerizable components, wherein the hydrophilic monomer is hydroxyethylmethacrylate, hydroxyethylacrylate, N-hydroxyethylmethacrylamide, N-hydroxyethylacrylamide, N,N-dimethylacrylamide, N,N-dimethylmethacrylamide, or a combination thereof,

(b) from about 20% to about 85% by weight of one or more poly(phenyl ether)-containing monomers of formula (I) relative to the total amount of all polymerizable components

wherein:

R 1 is H or CH 3 ;

R a , R b , R c , R d , R e , R f , R g , R h , and R i independent of one another are H, C 1 -C 12 alkyl, or C 1 -C 12 alkoxy;

B p is a direct bond, (CH 2 ) m1 , or (OCH 2 CH 2 ) m2 , in which m1 is 2-6 and m2 is 1-10;

n1 is an integer from 1 to 9;

n2 is an integer from 0 to 6;

Y p is a direct bond, O, S, OC(═O)NH, NHC(═O)NH, or NR′ in which R′ is H, C 1 -C 10 alkyl, C 6 H 5 , or CH 2 C 6 H 5 ,

(c) from 0 to about 50% by weight of one or more aryl acrylic monomers of formula (II) relative to the total amount of all polymerizable components

wherein A 1 is H or CH 3 ; B 1 is (CH 2 ) m1 or [O(CH 2 ) 2 ] Z1 in which m1 is 2-6 and z1 is 1-10; Y 1 is a direct bond, O, S, or NR″ in which R″ is H, CH 3 , C n′ H 2n′+1 in which n′=1-10, iso-OC 3 H 7 , C 6 H 5 , or CH 2 C 6 H 5 ; W1 is 0-6, provided that m1+w1≤8;

and D 1 is H, Cl, Br, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 6 H 5 , or CH 2 C 6 H 5 , and

(d) one or more polymerizable crosslinking agents,

wherein the listed components and any additional polymerizable components add up to 100% by weight,

wherein the intraocular lens material in a fully-hydrated state has: a glass transition temperature of less than 22° C., a refractive index of 1.55 or greater measured at 589 nm and at room temperature (23±2° C.), an equilibrium water content of less than 5.0% by weight at a temperature of from 16° C. to 45° C., a Young's modulus of less than 80 MPa, an elongation of at least 100%, a 100% secant modulus of less than 6.0 MPa, and a glistening resistance characterized by having no bright field microvacuoles and about 10 or less microvacuoles per viewing screen.

2. The intraocular lens material of claim 1 , wherein the intraocular lens material in the fully hydrated state has a surface light scattering of less than 30 CCT units (computer-compatible-tape units) after 10-years accelerated aging (90° C., 81 days in a Balanced Salt Solution, BSS).

3. The intraocular lens material according to claim 2 , wherein the polymerizable composition comprises from about 15% to about 25% by weight of the hydrophilic monomer.

4. The intraocular lens material according to claim 2 , wherein the polymerizable composition comprises from about 25% to about 75% by weight of said one or more poly(phenyl ether)-containing monomers of formula (I).

5. The intraocular lens material according to claim 2 , wherein the polymerizable composition comprises from about 10% to about 45% by weight of said one or more aryl acrylic monomers of formula (II).

6. The intraocular lens material of according to claim 2 , wherein the polymerizable composition comprises from about 1.0% to about 4.0% by weight of the polymerizable crosslinking agent.

7. The intraocular lens material according to claim 2 , wherein in formula (I), R a , R b , R c , R d , R e , R f , R g , R h , and R i independent of one another are H, n1 is an integer from 2 to 6, n2 is an integer from 0 to 4.

8. The intraocular lens material of claim 2 , wherein said one or more poly(phenyl ether)-containing monomers of formula (I) are selected from the group consisting of:

9. The intraocular lens material of claim 2 , wherein said one or more aryl acrylic monomers are: 2-ethylphenoxy acrylate; 2-ethylphenoxy methacrylate; phenyl acrylate; phenyl methacrylate; benzyl acrylate; benzyl methacrylate; 2-phenylethyl acrylate; 2-phenylethyl methacrylate; 3-phenylpropyl acrylate; 3-phenylpropyl methacrylate; 4-phenylbutyl acrylate; 4-phenylbutyl methacrylate; 4-methylphenyl acrylate; 4-methylphenyl methacrylate; 4-methylbenzyl acrylate; 4-methylbenzyl methacrylate; 2-2-methylphenylethyl acrylate; 2,2-methylphenylethyl methacrylate; 2,3-methylphenylethyl acrylate; 2,3-methylphenylethyl methacrylate; 2,4-methylphenylethyl acrylate; 2,4-methylphenylethyl methacrylate; 2-(4-propylphenyl)ethyl acrylate; 2-(4-propylphenyl)ethyl methacrylate; 2-(4-(1-methylethyl)phenyl)ethyl acrylate; 2-(4-(1-methylethyl)phenyl)ethyl methacrylate; 2-(4-methoxyphenyl)ethyl acrylate; 2-(4-methoxyphenyl)ethyl methacrylate; 2-(4-cyclohexylphenyl)ethyl acrylate; 2-(4-cyclohexylphenyl)ethyl methacrylate; 2-(2-chlorophenyl)ethyl acrylate; 2-(2-chlorophenyl)ethyl methacrylate; 2-(3-chlorophenyl)ethyl acrylate; 2-(3-chlorophenyl)ethyl methacrylate; 2-(4-chlorophenyl)ethyl acrylate; 2-(4-chlorophenyl)ethyl methacrylate; 2-(4-bromophenyl)ethyl acrylate; 2-(4-bromophenyl)ethyl methacrylate; 2-(3-phenylphenyl)ethyl acrylate; 2-(3-phenylphenyl)ethyl methacrylate; 2-(4-phenylphenyl)ethyl acrylate; 2-(4-phenylphenyl)ethyl methacrylate; 2-(4-benzylphenyl)ethyl acrylate; 2-(4-benzylphenyl)ethyl methacrylate; 2-(phenylthio)ethyl acrylate; 2-(phenylthio)ethyl methacrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-benzyloxyethyl methacrylate; 3-benzyloxypropyl methacrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl methacrylate; or combinations thereof.

10. The intraocular lens material of claim 2 , wherein said one or more aryl acrylic monomers are: 2-phenylethyl acrylate; 3-phenylpropyl acrylate; 4-phenylbutyl acrylate; 5-phenylpentyl acrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; their corresponding methacrylates, or combinations thereof.

11. The intraocular lens material of claim 2 , wherein the polymerizable crosslinking agents are selected from the group consisting of ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl methacrylate; 1,3-propanediol dimethacrylate; 2,3-propanediol dimethacrylate; 1,6-hexanediol dimethacrylate; 1,4-butanediol dimethacrylate; ethylene glycol diacrylate; diethylene glycol diacrylate; triethylene glycol diacrylate, tetraethylene glycol diacrylate, allyl acrylate; 1,3-propanediol diacrylate; 2,3-propanediol diacrylate; 1,6-hexanediol diacrylate; 1,4-butanediol diacrylate; N,N′-hexamethylene bisacrylamide; N,N′-hexamethylene bismethacrylamide; N,N′-dihydroxyethylene bisacrylamide; N,N′-dihydroxyethylene bismethacrylamide; N,N′-methylene bisacrylamide; N,N′-methylene bismethacrylamide; CH 2 ═C(CH 3 )C(═O)O—(CH 2 CH 2 O) p —C(═O)C(CH 3 )═CH 2 where p=1-50; CH 2 ═CHC(═O)O—(CH 2 CH 2 O) p —C(═O)CH═CH 2 where p=1-50; CH 2 ═C(CH 3 )C(═O)O(CH 2 ) t O—)C(CH 3 )═CH 2 where t=3-20; CH 2 ═CHC(═O)O(CH 2 ) t O—C(═O)CH═CH 2 where t=3-20, and combinations thereof.

12. The intraocular lens material of claim 11 , wherein the polymerizable crosslinking agents are selected from the group consisting of 1,6-hexanediol diacrylate, 1,4-butanediol diacrylate, N,N′-hexamethylene bisacrylamide, and combinations thereof.

13. The intraocular lens material of claim 2 , wherein the polymerizable composition comprises a polymerizable UV-absorbing agent.

14. The intraocular lens material of claim 13 , wherein the polymerizable UV-absorbing agent is 2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-methyl-6-(2-methylallyl)phenol, N-[2-[4-hydroxy-3-[2-(2-methylphenyl)diazenyl]phenyl]ethyl] methacryamide, or a combination thereof.

15. The intraocular lens material claim 2 , wherein the hydrophilic monomer is hydroxyethylmethacrylate, hydroxyethylacrylate, N-hydroxyethylacrylamide, N,N-dimethylacrylamide, or a combination thereof.

16. The intraocular lens material of claim 2 , wherein the hydrophilic monomer is hydroxyethylmethacrylate, hydroxyethylacrylate, or a combination thereof.

17. The intraocular lens material of claim 2 , wherein the hydrophilic monomer is hydroxyethylmethacrylate.

18. The intraocular lens material of claim 2 , wherein the intraocular lens material in the fully-hydrated state has at least one property selected from the group consisting of: a glass transition temperature of less than 17° C.; an equilibrium water content of from about 1% to about 4.5% by weight at a temperature of from 16° C. to 45° C.; a Young's modulus of from about 1 MPa to about 60 MPa; an elongation at break of at least 110%; a 100% secant modulus of about 4.5 MPa or less; and combinations thereof.

19. The intraocular lens material of claim 2 , wherein the intraocular lens material in the fully-hydrated state has a glass transition temperature of less than 12° C.; an equilibrium water content of from about 1.5% to about 4.0% by weight at a temperature of from 16° C. to 45° C.; a Young's modulus of from about 5 MPa to 20 MPa; an elongation at break of from 130% to 300%; a 100% secant modulus of about 3.0 MPa or less; and combinations thereof.

20. A wet-pack intraocular lens comprising or consisting essentially of an intraocular lens material of claim 2 .

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2016
From: JIANG, XUWEI; SCHLUETER, DOUGLAS; LAREDO, WALTER
To: ALCON RESEARCH, LTD.
Reel/Frame 038377/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2016
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 038377/0737 →
Cited By (3)
US 12,194,698 US 12,194,699 US 12,360,289